Latest retinopathy of prematurity Stories
CHOP Expert Leads Telemedicine Study Aimed at Improving Outcomes in Underserved Children PHILADELPHIA, June 26, 2014 /PRNewswire-USNewswire/ -- Trained non-physician evaluators who
LEXINGTON, Massachusetts, May 16, 2014 /PRNewswire/ -- - FDA submission planned for 1st Quarter 2015 - Shire forms business unit focused in ophthalmics
Eyedrops administered to infants as part of routine outpatient retinopathy of prematurity (ROP) screening can have life-threatening consequences.
A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies).
AMHERST, N.Y., Feb.
In a group of very low-birth-weight infants, severe retinopathy of prematurity was associated with nonvisual disabilities at age 5 years.
According to new research appearing this month in Ophthalmology, the journal of the American Academy of Ophthalmology (AAO), premature children face a much greater risk of eventually experiencing retinal detachment than their full-term counterparts.
In a randomized trial performed to help resolve the uncertainty about the optimal oxygen saturation therapy in extremely preterm infants.
The researchers behind a large study on the effects of oxygen levels on premature infants have been reprimanded by the US Department of Health and Human Services (HHS) for failing to inform the parents of those children of the risks involved with the study.